Back to Screener

908 Devices Inc. - Common Stock (MASS)

NASDAQ Small Cap

Healthcare › Measuring & Controlling Devices, NEC

$8.17
Market Cap: $309M
Data as of Mar 31, 2026 (TTM)

Price History

Feb 9, 2026 — May 11, 2026

Investment Snapshot

  • Trading 207% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 3/9 — signs of financial weakness
  • ROE of 2.5% — below-average profitability
  • Revenue declining 6% annually

908 Devices Inc. - Common Stock (MASS) is a Healthcare company operating in Measuring & Controlling Devices, NEC, listed on the NASDAQ , with a market capitalisation of $309 million . Key value metrics: P/E ratio 91.9, P/B ratio 2.30, Piotroski F-Score 3 out of 9 .

Value Score

Key Metrics

P/E Ratio
91.95
2.30
EPS
$0.09
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

908 Devices Inc. - Common Stock — Fundamental Analysis Summary

908 Devices Inc. - Common Stock (MASS) is currently trading 207% above its Graham Number of $2.66, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 91.9x.

On financial health, MASS shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and modest return on equity of 2.5% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.10.

StockPik's composite Value Score for MASS is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

MASS reports a solid gross margin of 50.1% (sector average: 40.1%) and a negative operating margin of -106.1%.

MASS shows revenue declining at 6% year-over-year, with earnings growing at 127%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
EMBC $3.90 2.1 100
HCM $13.31 5.1 100
GMAB $27.06 1.8 100
CGEN $2.71 7.3 100
INVA $22.89 5.8 100
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
MASK
Next
MAT